A study by Hu et al. showed that HDAC3-mediated increase in BCL-XL expression through the negative regulation of the miR-296-5p gene promoter inhibits lymphocyte apoptosis, increasing the risk of T1DM development [100]. The gene discussed is BCL2L1; the disease is type 1 diabetes mellitus.